Corneal Sensitivity in Chronic Inflammatory Demyelinating Polyneuropathy

被引:2
|
作者
Bansal, Surbhi [1 ]
Myneni, Ajay A. [2 ]
Mu, Lina [2 ]
Myers, Bennett H. [3 ]
Patel, Sangita P. [1 ,4 ,5 ]
机构
[1] SUNY Buffalo, Dept Ophthalmol, Sch Med & Biomed Sci, Ross Eye Inst, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Social & Prevent Med, Buffalo, NY 14260 USA
[3] Dent Neurol Inst, Dept Epidemiol & Environm Hlth, Buffalo, NY USA
[4] SUNY Eye Inst, New York, NY USA
[5] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY USA
关键词
chronic inflammatory demyelinating polyneuropathy; corneal ulcer; trigeminal neuropathy; corneal innervations; neurotrophic keratitis; VIVO-CONFOCAL-MICROSCOPY; POLYRADICULONEUROPATHY; KERATITIS; DISEASE;
D O I
10.1097/ICO.0000000000000145
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose:Neurotrophic keratitis may result from a variety of ocular or systemic diseases. Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune neuropathy that affects any nerve plexus but with no known association with corneal disease. We observed 2 patients with CIDP and visually compromising neurotrophic corneal ulcers. This study was performed to determine the prevalence of neurotrophic corneas in patients with CIDP to identify a subpopulation of asymptomatic patients who are at risk for vision loss.Methods:This is an observational case series of 2 patients with CIDP with visually compromising neurotrophic corneal ulcers and a prospective clinical study comparing corneal sensitivity in 9 patients with CIDP versus 9 age- and sex-matched controls. Corneal sensitivity was tested with an esthesiometer. Statistical analyses were performed to determine patterns or significances in relation to the subject's age, gender, and duration and severity of the disease.Results:The overall median corneal sensitivity was 5.7 for patients with CIDP and 6.0 for controls (P = 0.09). The mean corneal sensitivity was 5.6 0.4 in patients with CIDP compared with 5.8 0.3 in controls. No specific pattern was found with age, gender, or duration and severity of the disease among patients with CIDP.Conclusions:Although the case series demonstrated decreased corneal sensitivity in both patients with CIDP, the prospective study detected reduced corneal sensitivity in patients with CIDP when compared with controls, but did not reach statistical significance. Ophthalmic examinations with measurement of corneal sensitivity should be considered in the management of patients with CIDP.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01379833.
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [31] CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY AND MALIGNANCY: A SYSTEMATIC REVIEW
    Rajabally, Yusuf A.
    Attarian, Shahram
    MUSCLE & NERVE, 2018, 57 (06) : 875 - 883
  • [32] Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
    Rajabally, Yusuf A.
    Attarian, Shahram
    Delmont, Emilien
    JOURNAL OF INFLAMMATION RESEARCH, 2020, 13 : 543 - 549
  • [33] Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
    Tackenberg, Bjoern
    Nimmerjahn, Falk
    Luenemann, Jan D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 : S65 - S69
  • [34] Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy
    Tan, Cheng-Yin
    Arumugam, Thaarani
    Razali, Siti Nur Omaira
    Yahya, Mohd Azly
    Goh, Khean-Jin
    Shahrizaila, Nortina
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 57 : 198 - 201
  • [35] An approach to assessing immunoglobulin dependence in chronic inflammatory demyelinating inflammatory polyneuropathy
    Kapoor, Mahima
    Compton, Laura
    Rossor, Alex
    Hutton, Elsbeth
    Manji, Hadi
    Lunn, Mike
    Reilly, Mary
    Carr, Aisling
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (04) : 461 - 468
  • [36] Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
    Rajabally, Yusuf A.
    NEURAL REGENERATION RESEARCH, 2015, 10 (09) : 1399 - 1400
  • [37] Membrane properties in chronic inflammatory demyelinating polyneuropathy
    Cappelen-Smith, C
    Kuwabara, S
    Lin, CSY
    Mogyoros, I
    Burke, D
    BRAIN, 2001, 124 : 2439 - 2447
  • [38] ATYPICAL CHILDHOOD CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Mohamed, Ahmad R.
    Rodriguez-Casero, M. Victoria
    Ryan, Monique M.
    MUSCLE & NERVE, 2010, 42 (02) : 293 - 295
  • [39] Rituximab in refractory chronic inflammatory demyelinating polyneuropathy
    Muley, Suraj A.
    Jacobsen, Bill
    Parry, Gareth
    Usman, Uzma
    Ortega, Erik
    Walk, David
    Allen, Jeff
    Pasnoor, Mamatha
    Varon, Matthew
    Dimachkie, Mazen M.
    MUSCLE & NERVE, 2020, 61 (05) : 575 - 579
  • [40] Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy
    Furukawa, Soma
    Fukami, Yuki
    Hanamatsu, Hisatoshi
    Yokota, Ikuko
    Furukawa, Jun-ichi
    Hane, Masaya
    Kitajima, Ken
    Sato, Chihiro
    Hiraga, Keita
    Satake, Yuki
    Yagi, Satoru
    Koike, Haruki
    Katsuno, Masahisa
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)